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Abstract: 
Two types of antiviral treatments, namely, interferon and nucleoside/nucleotide analogues are available for hepatitis infections. The selection of drug and dose 
determined using known pharmacokinetics and pharmacodynamics data is important. The lack of sufficient information for pharmacokinetics of a drug may not 
produce the desired results. Artificial neural network (ANN) provides a novel model-independent approach to pharmacokinetics and pharmacodynamics data. 
ANN model is created by supervised learning of 90 patients sample to predict the treatment strategy (lamivudine only and Lamivudine + Interferon) on the basis of 
viral load, liver function test, visit number, treatment duration, ethnic area, sex, and age. The model was trained with 68 (77.3%) samples and tested with 20 
(22.7%) samples. The model produced 92% accuracy with 92.8% sensitivity and 83.3% specificity. 
 
 
Keywords: ANN (Artificial neural networks), Hepatitis, Prediction, Treatment 
 
 
 
 
Background: 
Viral hepatitis is one of the important public health problems. There are 350 
million patients, who are carrier of hepatitis B at present, worldwide [1]. The 
Majority of the Asian population is affected. Particularly the situation in 
Pakistan is alarming [2]. Pakistani population has a carrier rate of 3-4%. Some 
of the community based studies showed the presence of 31% hepatitis B core 
antibodies and 4.3% of hepatitis B surface antigen on tested samples [3]. There 
are two types of antiviral treatments, Interferon and nucleoside/nucleotide 
analogues. The expenses for antiviral treatment are considerable in developing 
and developed countries [1]. Hence the appropriate treatment selection has a 
major role in the cost and cure of the disease. The dose of the drug and 
selection of the drug can be determined by the knowledge of drug’s 
pharmacokinetics and pharmacodynamics.  The lack of sufficient information 
for pharmacokinetics of a drug may not produce the desired results. Artificial 
Neural Network (ANN) provides a novel model-independent approach to 
pharmacokinetics and pharmacodynamics data [4]. This is why ANN can 
predict the drug treatment accurately based on the factors or symptoms of the 
patients. ANN has been used as a prediction tool for classification and decision 
support in many fields like medicine [5]. ANN is based on artificial 
intelligence (AI) established in the area of computer sciences, which is capable 
of producing software which can do sophisticated, intelligent, and can perform 
computations similar to those of human brain [4]. Neural Networks collect the 
information by detecting relationship patterns in data as the brain does [4]. 
 
Computational artificial intelligence is mainly concerned with the construction 
of AI programs that perform diagnosis and make therapy recommendations 
based on purely statistical and probabilistic methods. [6] ANN provides a more 
advanced model of univariate and multivariate analysis, which imitates the 
nervous system in its function. It consists of a group of input and output 
neurons, simulating receptors and effectors, and a group of hidden neurons 
layer which simulates inter-neurons. [5] Neural Network is basically an 
interconnected assembly of simple processing elements, units or nodes, whose 
functionality is loosely based on the animal neuron. The processing ability of 
network is stored in the inter-unit connection strengths, or weights, obtained by 
process of adaptation to, or learning from, a set of training patterns [6]. The 
therapy recommendation is too important for the curing of hepatitis B 
especially with time duration. Hence the concept was developed to create an 
ANN system through supervised learning of Hepatitis B patients samples to 
predict the treatment strategy i.e. lamivudine only  or  lamivudine + Interferon   
on the basis of viral load, visit number, treatment duration, ethnic area, sex, and 
age. Following were the aims of this study. (a) To set up an artificial neural 
network system. (b) To develop a computational model to recommend the 
treatment plan of the newly registering patients based on ANN prediction. (c) 
To develop a database of hepatitis B patients. (d) To develop a Management 
Information System for handling present and upcoming HBV patients.  
 
Methodology: 
Sera samples were collected from HBV infected patients, DNA was extracted 
and then PCR was performed before the start of the treatment, at 3 months, at 6 
months and in follow up periods. Two types of treatment were given to the 
patients i.e. Lamivodine only and Lamivodine + Interferon. The complete 
demographic, diagnostic and treatment history of patients were being recorded. 
The front end of system was developed in Dot net technologies i.e. Visual 
Studio 2005, at backend a normalized database has been developed in MYSQL.  
 
Statistical Analysis and testing: 
Neural Network modeling was applied to get the required results by sigmoid 
activation function. ANN has been developed by creating single-layered 
Perceptron by Feed-forward Networks and back propagation methods through 
supervised learning of a sample of 90 patients to predict the treatment strategy. 
The sigmoid function was calculated through logistic regression. The system 
was built in two phases, in phase one the system was given training to learn and 
in second phase it was test against training. 
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Figure 1: Model Diagram. Where H(1:1) and H(1:2) are the hidden neurons 
 
Results and Discussion: 
Hepatitis B virus infections are well known to be the major cause of mortality 
and morbidity worldwide, especially among developing countries [7]. Hepatitis 
B is endemic in Africa, Eastern Europe, Asia and America [2]. Our study is 
primarily focused on Pakistani population. The Pakistan HBV infection rate is 
known to be increasing day by day owing to the lack of proper health facilities, 
poor economic status, etc. [7]. The drug selection for HBV infection is an 
important factor not only for the treatment of the disease, but also has an 
impact on the economic status of the country. The cost of anti-viral therapy is 
always considerably high, globally. In addition, the drug may have many side 
effects like fatigue, flu like syndrome etc. Most importantly, only a few 
patients may achieve a response after therapy [1]. Hence, prediction or 
suggestion of a treatment is crucial. Therefore, a system was developed which 
predicts accurate treatment and treatment procedure. In addition, a database 
information system was developed, to save the patient data. The latest 
technique used for accurate prediction is artificial neural networks, which is 
actually a novel independent approach to analyze the data for prediction [4]. 
For a linear relationship, certain assumptions must be met within the data. In 
case of data deviation from assumptions is met, assumptions-free modeling 
approach such as Artificial Neural Network is utilized.  
An ANN was developed by creating single layer Perceptron, Feed-forward 
Networks and back propagation method. The system was created through 
supervised learning of a sample of 90 patients, to predict the antiviral treatment 
strategy, i.e. Lamivodine only and Lamivodine+Interferon on the basis of viral 
load, visit number, treatment duration, ethnic area, sex, and age. In previous 
study it has been proved that the factors like age, genotype, viral load, Alt 
levels, and liver function tests are the strong predictors for antiviral therapy [1]. 
The same concept was carried out in another study where ANN was developed 
using SNP’s [9]. The age was categorized into two groups above 40 and below 
40 yrs. The viral load has two categories, below 10,000 and above 10,000. 
Ethnic area was categorized into NWFP, Punjab, Sindh and Baluchistan. There 
were 73 (81.1%) males and 17(18.9 %) females. Hence, the prevalence is high 
among males. 72 (80%) patients were below age 40 and 18 (20%) were above 
40, hence it is more common among young men. 38 (42.2%) patients belong to 
NWFP, 25 (27.8%) belong to Punjab, 16 (17.8%) from Sindh and 11(12.2%) 
from Baluchistan. The set of all known samples were broken into two 
orthogonal (independent) sets, training set and testing set to test the 
performance of the neural network. The system was provided with 68 (77.3%) 
samples to train the network, and 20 (22.7%) were tested against training. A 
total of six variables were used as input against which a hidden layer of two 
neurons were developed. The weights were assigned between the input and the 
hidden neurons. The weights of hidden neuron and output were calculated by 
using the Sigmoid Activation function (Table 1 see Supplementary material). 
In input layer, H (1:1) is the weight between the input and one hidden neuron in 
the hidden layer. H (1:2) is with neuron 2. While in hidden layer 1 the weights 
are H (1:1) and H (1:2) for the hidden neurons and the output. The diagram of 
the neural networks is shown in Figure 1. A significant reduction in the error 
was found with training and testing the system showing high precision level. 
The overall standard error (SE) of the system was 1.214. To validate the 
prediction model, we calculated sensitivity (SEN), specificity (SPE), positive 
prediction value (PPV) and negative prediction value (NPV). The overall 
accuracy by the ANN was 92% which is found to be almost same in another 
study of FFNN using SNP’s [9]. The value of SEN, Sep, PPV, and NPV were 
0.928, 0.8333, 0.93 and 0.83 respectively. 
 
Conclusion: 
We have developed a prediction model to predict the appropriate drug through 
an advanced methodology based on phenotypic characteristics. The results 
have shown that a trained ANN model is a promising method for providing the 
inference from measure of phenotypic traits. Our model achieves a higher 
successful rate of prediction and allows patients and doctors to make more 
informed decision. Based on the experience of appropriate therapy for HBV 
infection with this system we can predict 92% satisfactory therapy for the 
infection with low error rate. The error can be further reduced by increasing the 
sample size. The choice of the drug is not only helping to cure the disease but 
also it reduces the side effects of the drug and the cost of the therapy especially 
in the developing world.  
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Supplementary material: 
 
Table 1: Likelihood parameter estimates for synaptic weights 
Parameter Estimates 
Predictor     Predicted     
      Output Layer 
      H(1:1)  H(1:2)  treatment 
Input Layer  (Bias)  -0.36  0.43    
    [age_cat=.00]  -0.26 -0.28    
   [age_cat=1.00]  0.28  0.57    
    [viral_load=.00] -1.77 -0.51    
   [viral_load=1.00]  1.64  0.97    
   [gender=0]                 0.38  0.04    
   [gender=1]                 -0.58  -0.44    
   [Area=1   ]  0.10  0.65    
   [Area=2   ]  0.20  -0.76    
   [Area=3   ]  -0.88  -1.05    
   [Area=4   ]  1.60  1.18    
   Treatment 
duration 
3.74 0.93    
    Visit  -1.65 -1.32    
Hidden Layer 1  (Bias)        0.884305 
   H(1:1)        -4.37528 
   H(1:2)        -2.01677 
 
 
 